RABEPRAZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Rabeprazole patents expire, and when can generic versions of Rabeprazole launch?
Rabeprazole is a drug marketed by Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Usa, Chartwell Rx, Dr Reddys, Lannett Co Inc, Pharmobedient, Rubicon Research, Teva Pharms Usa, and Torrent. and is included in ten NDAs.
The generic ingredient in RABEPRAZOLE is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rabeprazole
A generic version of RABEPRAZOLE was approved as rabeprazole sodium by CHARTWELL RX on November 8th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for RABEPRAZOLE?
- What are the global sales for RABEPRAZOLE?
- What is Average Wholesale Price for RABEPRAZOLE?
Summary for RABEPRAZOLE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for RABEPRAZOLE |
| DailyMed Link: | RABEPRAZOLE at DailyMed |
US Patents and Regulatory Information for RABEPRAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 208644-001 | Apr 24, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 076885-001 | Nov 8, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 078964-001 | Nov 8, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rubicon Research | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 204237-001 | Nov 18, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal Pharms | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 204179-001 | Jul 31, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Usa | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 205761-001 | Feb 17, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
